112 related articles for article (PubMed ID: 15582685)
1. Evidence for bidirectional cues as a function of time following treatment with amphetamine: implications for understanding tolerance and withdrawal.
Barrett RJ; Caul WF; Smith RL
Pharmacol Biochem Behav; 2004 Dec; 79(4):761-71. PubMed ID: 15582685
[TBL] [Abstract][Full Text] [Related]
2. Long-lasting rebound cue effects following single doses of nicotine and amphetamine: implications for understanding tolerance.
Barrett RJ; Caul WF; Stadler JR; Smith RL
Psychopharmacology (Berl); 2001 Oct; 157(4):349-57. PubMed ID: 11605093
[TBL] [Abstract][Full Text] [Related]
3. Withdrawal, tolerance, and sensitization to dopamine mediated interoceptive cues in rats trained on a three-lever drug-discrimination task.
Barrett RJ; Caul WF; Smith R
Pharmacol Biochem Behav; 2005 May; 81(1):1-8. PubMed ID: 15894057
[TBL] [Abstract][Full Text] [Related]
4. An activity indicator of acute withdrawal depends on amphetamine dose in rats.
White W; White IM
Physiol Behav; 2006 Feb; 87(2):368-76. PubMed ID: 16364380
[TBL] [Abstract][Full Text] [Related]
5. Evidence for PTZ-like cues as a function of time following treatment with chlordiazepoxide: implications for understanding tolerance and withdrawal.
Barrett RJ; Smith RL
Behav Pharmacol; 2005 May; 16(3):147-53. PubMed ID: 15864069
[TBL] [Abstract][Full Text] [Related]
6. Tolerance, withdrawal, and supersensitivity to dopamine mediated cues in a drug-drug discrimination.
Barrett RJ; White DK; Caul WF
Psychopharmacology (Berl); 1992; 109(1-2):63-7. PubMed ID: 1365673
[TBL] [Abstract][Full Text] [Related]
7. Relationship between low-dose amphetamine-induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex.
Berridge CW; Stalnaker TA
Synapse; 2002 Dec; 46(3):140-9. PubMed ID: 12325041
[TBL] [Abstract][Full Text] [Related]
8. Characterizing withdrawal in rats following repeated drug administration using an amphetamine-vehicle-haloperidol drug discrimination.
Stadler JR; Caul WF; Barrett RJ
Psychopharmacology (Berl); 1999 Apr; 143(3):219-26. PubMed ID: 10353423
[TBL] [Abstract][Full Text] [Related]
9. Effects of short-term abstinence from escalating doses of D-amphetamine on drug and sucrose-evoked dopamine efflux in the rat nucleus accumbens.
Vacca G; Ahn S; Phillips AG
Neuropsychopharmacology; 2007 Apr; 32(4):932-9. PubMed ID: 16885936
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of prodynophin, c-fos, and serotonin transporter mRNA following withdrawal from a chronic, escalating dose regimen of D-amphetamine.
Horner KA; Noble ES; Lauterbach EC
Synapse; 2009 Apr; 63(4):257-68. PubMed ID: 19116947
[TBL] [Abstract][Full Text] [Related]
11. Development of acute withdrawal during periodic administration of amphetamine in rats.
White W; Feldon J; White IM
Pharmacol Biochem Behav; 2004 Sep; 79(1):55-63. PubMed ID: 15388284
[TBL] [Abstract][Full Text] [Related]
12. Effects of single or repeated amphetamine treatment and withdrawal on lung allergic inflammation in rats.
Ligeiro de Oliveira AP; Lazzarini R; Cavriani G; Quinteiro-Filho WM; Tavares de Lima W; Palermo-Neto J
Int Immunopharmacol; 2008 Sep; 8(9):1164-71. PubMed ID: 18602061
[TBL] [Abstract][Full Text] [Related]
13. Amphetamine withdrawal leads to behavioral sensitization and reduced HPA axis response following amphetamine challenge.
Russig H; Pryce CR; Feldon J
Brain Res; 2006 Apr; 1084(1):185-95. PubMed ID: 16563358
[TBL] [Abstract][Full Text] [Related]
14. Influence of chronic exercise on the amphetamine-induced dopamine release and neurodegeneration in the striatum of the rat.
Marques E; Vasconcelos F; Rolo MR; Pereira FC; Silva AP; Macedo TR; Ribeiro CF
Ann N Y Acad Sci; 2008 Oct; 1139():222-31. PubMed ID: 18991868
[TBL] [Abstract][Full Text] [Related]
15. Behavioural consequences of withdrawal from three different administration schedules of amphetamine.
Russig H; Murphy CA; Feldon J
Behav Brain Res; 2005 Nov; 165(1):26-35. PubMed ID: 16157394
[TBL] [Abstract][Full Text] [Related]
16. Characterization of interactions between phencyclidine and amphetamine in rodent prefrontal cortex and striatum: implications in NMDA/glycine-site-mediated dopaminergic dysregulation and dopamine transporter function.
Sershen H; Balla A; Aspromonte JM; Xie S; Cooper TB; Javitt DC
Neurochem Int; 2008 Jan; 52(1-2):119-29. PubMed ID: 17716783
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the long-term consequences of withdrawal from repeated amphetamine exposure in adolescence and adulthood on information processing and locomotor sensitization in mice.
Richetto J; Feldon J; Riva MA; Meyer U
Eur Neuropsychopharmacol; 2013 Feb; 23(2):160-70. PubMed ID: 22609316
[TBL] [Abstract][Full Text] [Related]
18. Prior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia.
Bédard AM; Maheux J; Lévesque D; Samaha AN
Schizophr Bull; 2013 May; 39(3):692-702. PubMed ID: 22927669
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D1 or D2 receptor antagonism within the basolateral amygdala differentially alters the acquisition of cocaine-cue associations necessary for cue-induced reinstatement of cocaine-seeking.
Berglind WJ; Case JM; Parker MP; Fuchs RA; See RE
Neuroscience; 2006; 137(2):699-706. PubMed ID: 16289883
[TBL] [Abstract][Full Text] [Related]
20. Amphetamine-induced behavioral activation is associated with variable changes in basal ganglia output neurons recorded from awake, behaving rats.
Gulley JM; Reed JL; Kuwajima M; Rebec GV
Brain Res; 2004 Jun; 1012(1-2):108-18. PubMed ID: 15158167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
